Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1993;133(3):407–421. doi: 10.1007/BF01313779

Targeted inhibition of immunodeficiency virus replication in lymphocytes through retroviral mediated gene transfer

F Y -T Tung 1, M D Daniel 2
PMCID: PMC7086800  PMID: 7504917

Summary

To test the feasibility of gene therapy for AIDS patients, an animal model is needed to evaluate the efficacy and safety of this approach. Antiviral genes (encoding antisense RNA or viral protein) derived from Simian immunodeficiency virus (SIV) were efficiently targeted into CD4+ lymphocytes through retroviral-mediated gene transfer. After challenging with infectious viruses, the transduced lymphocytes that received antiviral genes were not only protected from SIV infection, but also from infection with HIV, for at least 25 days. Furthermore, little or no cytolytic effect (syncytium formation) was observed in the protected cells. These data demonstrated that SIV or HIV replication could be effectively blocked by antisense sequence(s) or negative dominant factors which were introduced into targeted cells through retroviral-mediated gene transfer.

Keywords: Infectious Disease, Gene Therapy, Gene Transfer, Virus Replication, Viral Protein

References

  • 1.Baltimore D. Intracellular immunization. Nature. 1988;335:395–396. doi: 10.1038/335395a0. [DOI] [PubMed] [Google Scholar]
  • 2.Cepko C, Roberts BE, Mulligan RC. Construction and application of a highly transmissible murine retrovirus shuttle vector. Cell. 1984;37:1053–1062. doi: 10.1016/0092-8674(84)90440-9. [DOI] [PubMed] [Google Scholar]
  • 3.Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosier RC, Tiollais P, Sonigo P. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 1987;328:543–547. doi: 10.1038/328543a0. [DOI] [PubMed] [Google Scholar]
  • 4.Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M, Santos-Ferreira MO, Laurent AG, Dauguet C, Kaltama C, Rouzioux C, Klatzmann D, Champalimaud JL, Montagnier L. Isolation of a new human retrovirus from West African patients with AIDS. Science. 1986;233:343–346. doi: 10.1126/science.2425430. [DOI] [PubMed] [Google Scholar]
  • 5.Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC. Isolation of T-cell tropic HTLV-III-like retrovirus from macques. Science. 1985;228:1201–1204. doi: 10.1126/science.3159089. [DOI] [PubMed] [Google Scholar]
  • 6.Daniel MD, Letvin NL, Segal PK, Schmidt DK, Silvia DP, Solomon KR, Hodi FS, Ringler DJ, Hunt RD, King NW, Desrosiers RC. Prevalence of antibodies to three retroviruses in a capative colony of macaque antibodies to three retroviruses in a capative colony of macaque monkeys. Int J Cancer. 1988;41:601–608. doi: 10.1002/ijc.2910410421. [DOI] [PubMed] [Google Scholar]
  • 7.Daniel MD, Li Y, Naidu YM, Durda MJ, Schmidt DK, Troup CD, Silva DP, Mackey JJ, Kestler HW, III, Sehgal PK, King NW, Ohta Y, Hayami M, Desrosiers RC. Simian immunodeficiency virus from African Green monkeys. J Virol. 1988;63:4123–4128. doi: 10.1128/jvi.62.11.4123-4128.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Desrosiers RC. Simian immunodeficiency viruses. Annu Rev Microbiol. 1988;42:607–625. doi: 10.1146/annurev.mi.42.100188.003135. [DOI] [PubMed] [Google Scholar]
  • 9.Desrosiers RC, Wyand MS, Kodama T, Ringler DJ, Arthur LO, Sehgal PK, Letvin NL, King NW, Daniel MD. Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci USA. 1989;86:6353–6357. doi: 10.1073/pnas.86.16.6353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Eglitis MA, Kantoff PW, Gilboa E, Anderson WF. Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science. 1985;230:1395–1398. doi: 10.1126/science.2999985. [DOI] [PubMed] [Google Scholar]
  • 11.Eglitis MA, Kantoff PW, Jolly JD, Jones JB, Anderson WF, Lothrop CD., Jr Gene transfer into hematopoietic progenitor cells from normal and cyclic hematopoietic dogs using retroviral vectors. Blood. 1988;71:717–722. [PubMed] [Google Scholar]
  • 12.Evan LA, McHugh TM, Stites DP, Levy JA. Differential ability of human immunodeficiency virus isolates to productively infect human cells. J Immunol. 1987;138:3415–3418. [PubMed] [Google Scholar]
  • 13.Guild BC, Finer MH, Housman DE, Mulligan R. Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J Virol. 1988;62:3795–3801. doi: 10.1128/jvi.62.10.3795-3801.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular weight DNA from mammalian cells. Eur J Biochem. 1972;36:32. doi: 10.1111/j.1432-1033.1973.tb02881.x. [DOI] [PubMed] [Google Scholar]
  • 15.Joshi S, Brunschot AV, Asad S, Elst IVD, Read SE, Bernstein A. Inhibition of human immunodeficiency virus type I multiplication by antisense and sense RNA expression. J Virol. 1991;65:5524–5530. doi: 10.1128/jvi.65.10.5524-5530.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kitagawa M, Lackner AA, Martfeld DJ, Gardner MB, Dandekar S. Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo. Am J Pathol. 1991;138:921–930. [PMC free article] [PubMed] [Google Scholar]
  • 17.Laneuville P, Chang W, Kamel-Reid S, Fauser AA, Dick JE. High-efficiency gene transfer and expression in normal human hematopoietic cells with retrovirus vectors. Blood. 1988;71:811–814. [PubMed] [Google Scholar]
  • 18.Letvin NL, Daniel MD, Sehgal PK, Desrosiers RC, Hunt RD, Waldron LM, Mackey JJ, Schmidt DK, Chalifoux LV, King NW. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science. 1985;230:71–73. doi: 10.1126/science.2412295. [DOI] [PubMed] [Google Scholar]
  • 19.Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 1988;167:400–406. [PubMed] [Google Scholar]
  • 20.Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989;7:980–990. [PMC free article] [PubMed] [Google Scholar]
  • 21.Murphy-Corb M, Martin LM, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang JY, Putney SD, Allison AC, Eppstein DA. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science. 1989;246:1293–1297. doi: 10.1126/science.2555923. [DOI] [PubMed] [Google Scholar]
  • 22.Naidu YM, Kestler HW, III, Li Y, Butler CV, Silva DP, Schmidt DK, Troup CD, Sehgal PK, Sonigo P, Daniel MD, Desrosiers RC. Characterization of infectious molecular clones of Simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecular cloned SIVmac. J Virol. 1988;62:4091–4096. doi: 10.1128/jvi.62.12.4691-4696.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Palmer TD, Hock RA, Osborne WRA, Miller AD. Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc Natl Acad Sci USA. 1987;84:1055–1059. doi: 10.1073/pnas.84.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rafalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway SR, Jr, Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo R, Wong-Staal F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 1985;313:277–284. doi: 10.1038/313277a0. [DOI] [PubMed] [Google Scholar]
  • 25.Regier DA, Desrosiers RC. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses. 1990;6:1221–1231. doi: 10.1089/aid.1990.6.1221. [DOI] [PubMed] [Google Scholar]
  • 26.Rhodes A, James W. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol. 1990;71:1965–1974. doi: 10.1099/0022-1317-71-9-1965. [DOI] [PubMed] [Google Scholar]
  • 27.Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merina MJ, Culver K, Miller AD, Blaese RM, Anderson WF. Gene transfer into humans — immunotherapy of patients with advanced melanoma, using tumour-infiltrating lymphocytes modified by retroviral gene transduction. New infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 1990;323:570–578. doi: 10.1056/NEJM199008303230904. [DOI] [PubMed] [Google Scholar]
  • 28.Saag MS, Hahn BH, Gibbons J, Li Y, Parks ES, Parks WP, Shaw GM. Extensive variation of human immunodeficiency virus type 1 in vivo. Nature. 1988;334:440–447. doi: 10.1038/334440a0. [DOI] [PubMed] [Google Scholar]
  • 29.Sczakiel G, Pawlita M. Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol. 1991;65:468–472. doi: 10.1128/jvi.65.1.468-472.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sczakiel G, Oppenlander M, Rittner K, Pawlita M. Tat-and rev-directed antisense RNA expression inhibits and abolishes replication of human immunodeficiency virus type 1: a temporal analysis. J Virol. 1992;66:5576–5581. doi: 10.1128/jvi.66.9.5576-5581.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJL. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol. 1990;64:864–872. doi: 10.1128/jvi.64.2.864-872.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tersmette M, Goede R, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolate: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol. 1988;62:2026–2032. doi: 10.1128/jvi.62.6.2026-2032.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Trono DM, Feinberg B, Baltimore D. HIV-1 gag mutant can dominantly interfere with the replication of the wild-type virus. Cell. 1989;59:113–120. doi: 10.1016/0092-8674(89)90874-x. [DOI] [PubMed] [Google Scholar]
  • 34.Tung FYT, Abraham S, Sethna M, Hung SL, Sethna P, Hogue BG, Brian DA. The 9-kDa hydrobphobic protein encoded at the 3′ end of the porcine transmissible gastroenteritis coronavirus genome is membrane-associated. Virology. 1992;186:676–683. doi: 10.1016/0042-6822(92)90034-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tung FYT (1993) A 3.5 kbp cDNA encoding the peplomer gene of TGEV was subcloned into MNC vector under the control of cytomegalovirus early promoter (unpublished)

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES